News
Emphasis must be on balancing enforcement with innovation, protection with access, and litigation with alternative dispute resolution ...
The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...
Shares of Glenmark Pharmaceuticals jumped 10% in early trade on Friday, a day after a unit of the Indian drugmaker signed an exclusive licensing deal with U.S. peer AbbVie for its cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results